Header Logo

Connection

Lewis Hassell to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Lewis Hassell has written about Protein Kinase Inhibitors.
Lewis Hassell
Connection Strength
0.664
Protein Kinase Inhibitors
  1. Efficacy and Safety of Crizotinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with ROS1 Rearrangement or MET Alteration: A Systematic Review and Meta-Analysis. Target Oncol. 2020 10; 15(5):589-598.
    View in: PubMed
    Score: 0.664
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.